Specify a stock or a cryptocurrency in the search bar to get a summary
BioGaia AB (publ)
BGLAFBioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden. Address: Kungsbroplan 3, Stockholm, Sweden, 112 27
Analytics
WallStreet Target Price
1 747.42 SEKP/E ratio
32.2755Dividend Yield
1.78 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BGLAF
Dividend Analytics BGLAF
Dividend growth over 5 years
68 %Continuous growth
2 yearsPayout Ratio 5 years average
34 %Dividend History BGLAF
Stock Valuation BGLAF
Financials BGLAF
Results | 2019 | Dynamics |